Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding GB:CURE?
Track your performance easily
GB:CURE Price & Analysis
CURE ETF Chart & Stats
Day’s Range― - ―
52-Week Range$16.25 - $21.48
Previous Close$19.98
VolumeN/A
Average Volume (3M)114.00
AUM7.04M
NAV19.80
Expense Ratio0.35%
Holdings Count54
Beta0.86
Inception DateSep 02, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares OutstandingN/A
Standard DeviationN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume114
AlphaN/A
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Fund Flow Chart
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) 1 year Net Flows: $831K
CURE ETF News
PremiumCompany Announcements
Moderna Reshuffles Board, Adds Carlyle Co-Founder
CURE ETF FAQ
What was GB:CURE’s price range in the past 12 months?
GB:CURE lowest ETF price was $16.25 and its highest was $21.48 in the past 12 months.
What is the AUM of GB:CURE?
As of Jul 22, 2024 The AUM of GB:CURE is 7.04M.
Is GB:CURE overvalued?
According to Wall Street analysts GB:CURE’s price is currently Undervalued.
Does GB:CURE pay dividends?
GB:CURE does not currently pay dividends.
How many shares outstanding does GB:CURE have?
Currently, no data Available
Which hedge fund is a major shareholder of GB:CURE?
Currently, no hedge funds are holding shares in GB:CURE
CURE ETF Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Vertex Pharmaceuticals Inc.
8.20%
Regeneron Pharmaceuticals
8.20%
Dexcom
6.09%
Illumina
5.86%
Veeva Systems Inc
5.84%
Moderna
5.71%
Alnylam Pharmaceuticals
5.42%
Sarepta Therapeutics Inc.
4.59%
Natera Inc.
4.30%
Biontech Se Sponsored Adr
3.63%
Total57.84%
ETF Description
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD
The Funds investment objective is to replicate the price and the performance, before fees and expenses, of an index that provides exposure to the performance of a representative portfolio of companies involved in the genomic healthcare and electronic healthcare industries